Determination and distribution of N-acetyl- and N-glycolylneuraminic acids in culture media and cell associated glycoconjugates from human malignant mesothelioma and adenocarcinoma cells

Biomedical Chromatography

Volumn 20, Issue 5, 2006, Pages 434-439

  Tzanakakis, G N ^a   Syrokou, A ^b   Kanakis, I ^b   Karamanos, N K ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Adenocarcinoma; Mesothelioma; N acetylneuraminic acid; N glycolylneuraminic acid; Sialic acids

Indexed keywords

CARBOHYDRATES; CARBOXYLIC ACIDS; CELL CULTURE; DIAGNOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TUMORS;

ADENOCARCINOMA; ADENOCARCINOMA CELLS; CELL LINES; CULTURE MEDIUM; GLYCOCONJUGATES; MALIGNANT MESOTHELIOMA; MESOTHELIOMA; N-ACETYLNEURAMINIC ACID; N-GLYCOLYLNEURAMINIC ACID; SIALIC ACIDS;

FIBROBLASTS;

GLYCOCONJUGATE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PHENOTYPE; PLEURA EFFUSION; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 33646795623     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.573     Document Type: Article

References (31)

1. Bhavanandan VP and Furukawa K. In Biology of the Sialic Acids, Rosenberg A (ed.). Plenum Press: New York, 1995; 145-196.
2. Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ and Fuller JH. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care 2001; 24: 316-322.
3. Diamatopoulou S, Stagiannis KD, Vasilopoulos K, Barlas P, Tsegenidis T and Karamanos NK. Importance of high-performance liquid chromatographic analysis of serum N-acylneuraminic acids in evaluating surgical treatment in patients with early endometrial cancer. Journal of Chromatography B: Biomedical Sciences and Applications 1999; 732: 375-381.
4. Dobra K, Andang M, Syrokou A, Karamanos NK and Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Experimental Cell Research 2000; 258: 12-22.
5. Gottschalk A. Sialic acids: their molecular structure and characteristic reactions. Arzneimittelforschung 1960; 10: 355-357.
6. Hrncir Z, Pidrman V, Tichy M and Hamet A. Serum sialic acid in acute myocardial infarct during a dynamic follow-up. Vnitr Lek 1995; 21: 436.
7. Karamanos NK, Wikström B, Antonopoulos CA and Hjerpe A. Determination of N-acetyl- and N-glycolylneuraminic acids in glycoconjucates by reversed-phase high performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1990a; 503: 421-430.
8. Karamanos NK, Aletras AJ, Antonopoulos CA, Hjerpe A and Tsiganos CP. Chondroitin proteoglycans from squid skin. Isolation, characterization and immunological studies. European Journal of Biochemistry 1990b; 192: 33-38.
9. Karamanos NK, Manouras A, Anagnostides S, Makatsori E, Tsegenidis T and Antonopoulos CA. Isolation, biochemical and immunological characterization of two sea urchin glycoproteins bearing sulphated poly(sialic acid) polysaccharide rich in N-glycolyl neuraminic acid. Biochimie 1996; 78: 171-182.
10. Karamanos NK and Hjerpe A. High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma. Journal of Chromatography B: Biomedical and Sciences Applications 1997; 697: 277-281.
11. Klominek J, Robert KH, Hjerpe A, Wikström B and Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Research 1989; 49: 6118-6122.
12. Klominek J, Robert KH, Bergh J, Hjerpe A, Gahrton G and Sundqvist KG. Production of a motility factor by a newly established lung adenocarcinoma cell line. Anticancer Research 1998; 18: 759-67.
13. Lamari FN and Karamanos NK. Separation methods for sialic acids and critical evaluation of their biologic relevance. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2002; 781: 3-19.
14. Makatsori E, Karamanos NK, Anastassiou ED, Hjerpe A and Tsegenidis T. Screening of N-acylneuraminic acids in serum and tissue specimens of mouse C57BI with Lewis' lung cancer by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 1998a; 712: 23-29.
15. Makatsori E, Karamanos NK, Anastassiou ED, Hjerpe A and Tsegenidis T. A method to quantitate total sialic acid, glucosamine and galactosamine in blood serum and glycoconjugates by HPLC. Journal of Liquid Chromatography and Related Technologies 1998b; 21: 3031-3045.
16. Makatsori E, Aletras A, Karamanos NK and Tsegenidis T. Analysis of N-acetyl and N-glycolylneuraminic acid in rat serum and tissues with Walker 256 carcinoma by high-performance liquid chromatography. Biomedical Chromatography 1999; 13: 57-60.
17. Malykh YN, Schauer R and Shaw L. N-Glycolylneuraminic acid in human tumours. Biochimie 2001; 83: 623-634.
18. Nurminen M, Dejmek A, Martensson G, Thylen A and Hjerpe A. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clinical Chemistry 1994; 40: 777-780.
19. Reuter G and Shauer R. In Guide to Techniqes in Glycobiology, Lennarz WJ and Hart GW (eds). Academic Press: New York, 1994; 176-188.
20. Schauer R. In Sialic Acids: Chemistry, Metabolism and Function. Cell Biology Monographs, Vol. 10, Springer: New York 1982.
21. Stefenelli N, Klotz H, Engell A and Bauer P. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. Journal of Cancer Research and Clinical Oncology 1985; 109: 55-59.
22. Strousopoulou K, Militsopoulou M, Stagiannis K, Lamari FN and Karamanos NK. A capillary zone electrophoresis method for determining N-acetylneuraminic acid in glycoproteins and blood sera. Biomedical Chromatography 2002; 16: 146-150.
23. Syrokou A, Tzanakakis GN, Tsegenidis T, Hjerpe A and Karamanos NK. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Proliferation 1999a; 32: 85-99.
24. Syrokou A, Tzanakakis GN, Hjerpe A and Karamanos NK. Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. Biochimie 1999b; 81: 733-744.
25. Syrokou A, Dobra K, Tzanakakis GN, Hjerpe A and Karamanos NK. Synthesis and expression of mRNA encoding for different versican splice variants is related to the aggregation of human epithelial mesothelioma cells. Anticancer Research 2002; 22: 4157-4162.
26. Tjandra JJ, Sacks NP, Thompson CH, Leyden MJ, Stacker SA, Lichtenstein M, Russell IS, Collins JP, Andrews JT, Pieterst GA and McKenzie IFC. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study. British Journal of Cancer 1989; 59: 296-302.
27. Tsegenidis T and Karamanos NK. Sample clean-up and analysis of N-acetyl and N-glycolylneuraminic acids in blood serum and tissue specimen by HPLC. Journal of Liquid Chromatography and Related Technologies 1998; 21: 793-802.
28. Tzanakakis GN, Karamanos NK, Klominek J and Hjerpe A. Glycosaminoglycans from two human malignant mesothelioma cell lines. Distribution and effect of plateled derived growth factor on their synthesis. Biochemistry and Cell Biology 1995; 73: 59-66.
29. Tzanakakis GN, Hjerpe A and Karamanos NK Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated throuhgt specific receptors and the tyrosine kinase intracellular pathway. Biochimie 1997; 79: 323-332.
30. Vazquez AM, Gari MR, Hernandez AM, Alonso DF, Beausoleil I, Gomez DE and Perez R. Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides. Oncology Reports 2000; 7: 751-756.
31. Zhang Y, Zhang X-Y, Liu F, Qi H-L and Chen H-L. The roles of terminal sugar residues of surface glycans in the metastatic potential of human hepatocarcinoma. Journal of Cancer Research and Clinical Oncology 2002; 128: 617-620.